home / stock / lgstw / lgstw quote
Last: | $0.0601 |
---|---|
Change Percent: | -27.21% |
Open: | $0.0547 |
Close: | $0.0601 |
High: | $0.07 |
Low: | $0.0547 |
Volume: | 56,977 |
Last Trade Date Time: | 02/14/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0601 | $0.0547 | $0.0601 | $0.07 | $0.0547 | 56,977 | 02-14-2024 |
$0.043 | $0.045 | $0.043 | $0.0451 | $0.043 | 13,946 | 02-13-2024 |
$0.045 | $0.0547 | $0.045 | $0.0547 | $0.045 | 8,856 | 02-12-2024 |
$0.03 | $0.0496 | $0.03 | $0.05 | $0.03 | 3,242 | 02-09-2024 |
$0.04 | $0 | $0.04 | $0 | $0 | 30 | 02-08-2024 |
$0.04 | $0.055 | $0.04 | $0.055 | $0.04 | 1,385 | 02-07-2024 |
$0.03 | $0.05 | $0.03 | $0.05 | $0.03 | 1,607 | 02-06-2024 |
$0.0401 | $0.05 | $0.0401 | $0.05 | $0.0401 | 3,926 | 02-05-2024 |
$0.0405 | $0.044 | $0.0405 | $0.0574 | $0.0391 | 80,305 | 02-02-2024 |
$0.0416 | $0.06 | $0.0416 | $0.06 | $0.0416 | 20,640 | 02-01-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.0451 | 5,729 | 01-31-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 100,132 | 01-30-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.0515 | 19,522 | 01-26-2024 |
$0.06 | $0.0599 | $0.06 | $0.06 | $0.055673 | 14,180 | 01-25-2024 |
$0.058 | $0 | $0.058 | $0 | $0 | 270 | 01-24-2024 |
$0.058 | $0.048 | $0.058 | $0.0599 | $0.048 | 10,650 | 01-23-2024 |
$0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 3,100 | 01-18-2024 |
$0.03 | $0.03 | $0.03 | $0.0353 | $0.03 | 145,000 | 01-16-2024 |
$0.035 | $0.04 | $0.035 | $0.04 | $0.035 | 27,388 | 01-15-2024 |
$0.035 | $0.04 | $0.035 | $0.04 | $0.035 | 27,388 | 01-12-2024 |
News, Short Squeeze, Breakout and More Instantly...
Semper Paratus Acquisition Corporation Warrant Company Name:
LGSTW Stock Symbol:
NASDAQ Market:
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for large patient populations. WARREN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding...
New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the...
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that it has filed a supplement (“Prospectus Supplement”) to its defin...